Abstract
There is a heavy research emphasis on prognostic and predictive approaches based on genomic data, which has in turn challenged standard paradigms for the management of patients with malignant disease. This review will highlight the recent advances made in genomic medicine, specifically with regard to prognosis associated with thyroid cancer, cutaneous melanoma, and pancreatic adenocarcinoma. Although none of the markers reviewed have been incorporated into routine clinical practice, this review covers the most promising ones.
Original language | English (US) |
---|---|
Pages (from-to) | 31-37 |
Number of pages | 7 |
Journal | Journal of Surgical Oncology |
Volume | 111 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2015 |
Keywords
- BRAF
- Genomic medicine
- Prognosis
ASJC Scopus subject areas
- Surgery
- Oncology